FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology. In order to predict development of metachronous hyperplastic processes in organs of female reproductive system analysis of neoangiogenesis in tissue of malignant tumour of mammary gland ablated during operation is performed. If coefficient of ratio of vessel endothelium growth factor level to epidermal growth factor in malignant tumour tissue equals 2.5+0.2, development of metachronously developing hyperplastic process in uterus body in patients with breast cancer is predicted.
EFFECT: method makes it possible to predict metachronously developing hyperplastic process in uterus body before their clinical manifestation in patients with breast cancer.
1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PROGNOSIS OF DISEASE COURSE IN PATIENTS WITH UTERINE BODY CANCER | 2008 |
|
RU2395097C1 |
| METHOD FOR PREDICTION OF DEVELOPING MALIGNANT AND BENIGN UTERINE PATHOLOGY | 2011 |
|
RU2484473C2 |
| METHOD FOR PREDICTING RELAPSE DEVELOPMENT AT UTERINE BODY CANCER | 2002 |
|
RU2250077C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF METACHRONIC MAMMARY CANCER | 2003 |
|
RU2246248C1 |
| METHOD FOR PREDICTION OF DEVELOPING METACHRONOUS COLON CANCER | 2010 |
|
RU2447447C1 |
| METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
| METHOD OF DETERMINATION OF ORIENTATION OF PATHOLOGICAL PROCESS AT CANCER OF OVARIES | 2007 |
|
RU2350966C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS | 2011 |
|
RU2469651C2 |
| METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
| METHOD OF PREDICTING EFFICIENCY OF NEOADJUVANT CHEMOTHERAPY IN CASE OF LOCALLY ADVANCED OVARIAN CARCINOMA | 2008 |
|
RU2383339C1 |
